Loading page...

Back
RFA-DK-27-146 Open
Send to:
National Institutes of Health United States

New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies (R01 - Clinical Trial Optional)

Open

Overview

Funding agency
National Institutes of Health HHS-NIH11
Reference
RFA-DK-27-146
Region
United States
Source
Grants.gov (US Federal)

Description

The purpose of this funding opportunity is to support research addressing barriers that limit progress toward more effective open- and closed-loop diabetes control systems. This may include research that addresses: 1) innovation of sensing relevant analytes/physiologic signals; 2) novel formulation and delivery of hormones; 3) artificial intelligence (AI)/machine learning (ML)-driven…

Sign up to view full grant details

Create a free account to unlock the complete grant description, funding details, eligibility criteria, and application links.

Full description Funding amounts & eligibility Application links & deadlines Save & track grants

Related grants

Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) National Institutes of Health Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) National Institutes of Health Research Grants in Clinical Informatics (R01 Clinical Trial Optional) National Institutes of Health

Send to CRM

CRM Integration Required

To send grants directly to your CRM, you need to connect your CRM system to TenderPipe first.

Configure CRM in Settings

Email Grant

Scroll to Top